{"transactions":[{"id":3584241,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-20T20:02:25.000Z","date":"2019-03-18","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":73307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-19-004095","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/edgar.xml","form_type":"4"}},{"id":3584240,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-03-20T20:02:25.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":3000,"price":24.5,"value":73500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-19-004095","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/edgar.xml","form_type":"4"}},{"id":3584239,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-03-20T20:02:25.000Z","date":"2019-03-18","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-19-004095","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/edgar.xml","form_type":"4"}},{"id":3638088,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-22T21:11:26.000Z","date":"2019-02-20","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":76307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-19-002313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/edgar.xml","form_type":"4"}},{"id":3638087,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-02-22T21:11:26.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":3000,"price":20.42,"value":61260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.31 to $20.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-19-002313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/edgar.xml","form_type":"4"}},{"id":3638086,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-02-22T21:11:26.000Z","date":"2019-02-20","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-19-002313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/edgar.xml","form_type":"4"}},{"id":3667611,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-09T00:35:38.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001179110-19-001682","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001682/edgar.xml","form_type":"4"}},{"id":3667610,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-09T00:35:38.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023."}],"balance_after":48750,"derivative":{"exercise_price":21.1,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001179110-19-001682","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001682/edgar.xml","form_type":"4"}},{"id":3676597,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-04T22:32:04.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":16722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020."}],"balance_after":16722,"derivative":{"underlying":"Common Stock","underlying_shares":16722},"source":{"system":"sec-edgar","filing":"0001179110-19-001237","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001237/edgar.xml","form_type":"4"}},{"id":3691567,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":52897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3691566,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-17","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":79307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3691565,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-18","kind":"sale","acquired":false,"shares":4000,"price":26.5,"value":106000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3691564,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":4000,"price":11.21,"value":44840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3691563,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-17","kind":"sale","acquired":false,"shares":3000,"price":26.18,"value":78540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.03 to $26.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3691562,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-19T01:58:12.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-19-002543","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/a4.xml","form_type":"4"}},{"id":3724273,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":56897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724272,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":82307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724271,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":4000,"price":27.41,"value":109640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $27.16 to $27.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724270,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":4000,"price":11.21,"value":44840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724269,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":700,"price":28.34,"value":19838.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $28.22 to $28.53. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724268,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":2300,"price":27.75,"value":63825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.22 to $28.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3724267,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-12-19T21:41:06.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-18-014142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/edgar.xml","form_type":"4"}},{"id":3754280,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-20","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":60897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754279,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-19","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":85307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754278,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":4000,"price":26.5,"value":106000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754277,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-20","kind":"exercise","acquired":true,"shares":4000,"price":11.21,"value":44840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754276,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":300,"price":28.85,"value":8655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $28.82 to $28.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754275,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-19","kind":"exercise","acquired":true,"shares":300,"price":0.65,"value":195.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754274,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":2700,"price":28.12,"value":75924.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.73 to $28.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3754273,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-11-21T21:03:27.000Z","date":"2018-11-19","kind":"exercise","acquired":true,"shares":2700,"price":0.65,"value":1755.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":2700,"source":{"system":"sec-edgar","filing":"0001179110-18-013070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/edgar.xml","form_type":"4"}},{"id":3786246,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":64897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3786245,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-17","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":88307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3786244,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-18","kind":"sale","acquired":false,"shares":4000,"price":29.44,"value":117760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $29.10 to $29.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3786243,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-18","kind":"exercise","acquired":true,"shares":4000,"price":11.21,"value":44840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3786242,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-17","kind":"sale","acquired":false,"shares":3000,"price":28.87,"value":86610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.21 to $29.08. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3786241,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-10-19T20:01:48.000Z","date":"2018-10-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-18-012272","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/edgar.xml","form_type":"4"}},{"id":3811432,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on October 27, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":68897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3811431,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":91307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3811430,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-18","kind":"sale","acquired":false,"shares":4000,"price":32.19,"value":128760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $31.72 to $32.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3811429,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-18","kind":"exercise","acquired":true,"shares":4000,"price":11.21,"value":44840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3811428,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":3000,"price":32.33,"value":96990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3811427,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-09-19T20:03:51.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-18-011549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/edgar.xml","form_type":"4"}},{"id":3836903,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-20","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on October 27, 2016, and the remaining 75% of the shares schedule to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":72897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836902,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-17","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":94307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836901,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-20","kind":"sale","acquired":false,"shares":400,"price":30.41,"value":12164.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $30.34 to $30.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836900,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-20","kind":"exercise","acquired":true,"shares":400,"price":11.21,"value":4484.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836899,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-20","kind":"sale","acquired":false,"shares":3600,"price":29.81,"value":107316.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $29.30 to $30.23. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836898,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-20","kind":"exercise","acquired":true,"shares":3600,"price":11.21,"value":40356.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3600,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836897,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":3000,"price":29.65,"value":88950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.25 to $30.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3836896,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-21T20:09:53.000Z","date":"2018-08-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-18-010732","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/edgar.xml","form_type":"4"}},{"id":3864271,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-18","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on October 27, 2016, and the remaining 75% of the shares schedule to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":76897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864270,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-17","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":97307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864269,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-18","kind":"sale","acquired":false,"shares":850,"price":36.25,"value":30812.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $36.12 to $36.45. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864268,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-18","kind":"exercise","acquired":true,"shares":850,"price":11.21,"value":9528.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":850,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864267,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-18","kind":"sale","acquired":false,"shares":6150,"price":35.46,"value":218079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.11 to $36.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864266,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-18","kind":"exercise","acquired":true,"shares":6150,"price":11.21,"value":68941.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":6150,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864265,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-17","kind":"sale","acquired":false,"shares":4000,"price":36.5,"value":146000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864264,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-17","kind":"exercise","acquired":true,"shares":4000,"price":0.65,"value":2600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864263,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-17","kind":"sale","acquired":false,"shares":3000,"price":34.66,"value":103980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3864262,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-07-19T20:07:59.000Z","date":"2018-07-17","kind":"exercise","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-18-009834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/edgar.xml","form_type":"4"}},{"id":3886814,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-19","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on October 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on October 27, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019."}],"balance_after":83897,"derivative":{"exercise_price":11.21,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886813,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-18","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on April 30, 2015 and is scheduled to vest over four years with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019."}],"balance_after":104307,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886812,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":7000,"price":38.39,"value":268730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $38.00 to $38.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886811,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-19","kind":"exercise","acquired":true,"shares":7000,"price":11.21,"value":78470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886810,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":2700,"price":38.71,"value":104517.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $38.35 to $38.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886809,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-18","kind":"exercise","acquired":true,"shares":2700,"price":0.65,"value":1755.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":2700,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886808,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":4300,"price":37.75,"value":162325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.34 to $38.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}},{"id":3886807,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":158933,"kind":"person","name":"Myer Vickesh","position":1,"cik":"0001742806","reported_name":"Myer Vickesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-20T20:57:43.000Z","date":"2018-06-18","kind":"exercise","acquired":true,"shares":4300,"price":0.65,"value":2795.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017."}],"balance_after":4300,"source":{"system":"sec-edgar","filing":"0001179110-18-008837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/edgar.xml","form_type":"4"}}]}